Predicting pathological response of locally advanced breast cancer to neoadjuvant chemotherapy: comparing the performance of whole body 18F-FDG PETCT versus DCE-MRI of the breast
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-4762
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predicting pathological response of locally advanced breast cancer to neoadjuvant chemotherapy: comparing the performance of whole body 18F-FDG PETCT versus DCE-MRI of the breast ; volume:53 ; number:1 ; day:31 ; month:3 ; year:2022 ; pages:1-13 ; date:12.2022
The Egyptian Journal of Radiology and Nuclear Medicine ; 53, Heft 1 (31.3.2022), 1-13, 12.2022
- Urheber
-
Sobhi, Alaa
Talaat hamed, Soha
Hussein, El-shaymaa
Lasheen, Shaimaa
Hussein, Mai
Ebrahim, Youstina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-022-00743-x
- URN
-
urn:nbn:de:101:1-2022061921191247425527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sobhi, Alaa
- Talaat hamed, Soha
- Hussein, El-shaymaa
- Lasheen, Shaimaa
- Hussein, Mai
- Ebrahim, Youstina
- SpringerLink (Online service)
Ähnliche Objekte (12)
PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Automatic breast lesion segmentation in phase preserved DCE-MRIs
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Development and validation of a four-dimensional registration technique for DCE breast MRI
Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Neoadjuvant nab-paclitaxel in the treatment of breast cancer
PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Automatic breast lesion segmentation in phase preserved DCE-MRIs
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Development and validation of a four-dimensional registration technique for DCE breast MRI
Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Neoadjuvant nab-paclitaxel in the treatment of breast cancer
PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Automatic breast lesion segmentation in phase preserved DCE-MRIs
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy
Development and validation of a four-dimensional registration technique for DCE breast MRI
Erratum to: Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI